RSV Post-Authorization Data and Second-Season Protection: Emerging Evidence ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDSJune 29th 2026
RSV Efficacy vs. Real-World Effectiveness: What the Data RevealByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDSJune 29th 2026
Linaclotide in Pediatric IBS-C—Evidence, Indications, and Practical UseByJulie Khlevner, MD, AGAFJune 24th 2026
RSV Monoclonal Antibody Resistance: What Clinicians Need to KnowByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDSJune 22nd 2026
RSV Maternal Immunization vs. Monoclonal Antibodies: Comparing Immunity and Practical DifferencesByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDSJune 22nd 2026